ARTICLE | Company News
Creative BioMolecules other research news
October 18, 1993 7:00 AM UTC
CBMI received a $500,000 Phase II SBIR grant from the National Institute of Dental Research to fund clinical development of PDGF/DEX to treat periodontal disease. When platelet derived growth factor (...